Brief: Vaxil Provides Update On Usamriid, Oral Experiment And Other General Business Matters

Vaxil Bio

27/01/2021 12:57

Jan 27 (Reuters) - Vaxil Bio Ltd  VXL.V :
    * VAXIL PROVIDES UPDATE ON USAMRIID, ORAL EXPERIMENT AND
OTHER
GENERAL BUSINESS MATTERS
    * VAXIL BIO LTD - MICE RECEIVED THREE SCHEDULED VACCINATIONS
BY
DECEMBER 31, 2020 AND RESPONDED NORMALLY TO INJECTIONS
ADMINISTERED
    * VAXIL BIO LTD - MICE HAVE DEVELOPED AN IMMUNE RESPONSE, AS
EXPECTED, AND CONSISTENT WITH PREVIOUS IN VIVO (ANIMAL) RESULTS
    * VAXIL BIO LTD - EXPECTS TO PROVIDE FURTHER UPDATES IN
FIRST HALF
OF FEBRUARY 2021
    * VAXIL BIO LTD - MEDIATION PROCESS WAS NOT SUCCESSFUL AND
COMPANY
HAS BEEN NAMED AS A DEFENDANT IN AN ACTION RECENTLY COMMENCED BY
 ISAAC MARESKY

Source text for Eikon:  ID:nGNX9dTF8S 
Further company coverage:  VXL.V 

 ((Reuters.Briefs@thomsonreuters.com;))